Intracerebral hemorrhage (ICH) is the second most common subtype of stroke and a critical
disease usually leading to severe disability or death. ICH is more common in Asians …

Importance Intracerebral hemorrhage (ICH) is the most devastating adverse event in
patients receiving oral anticoagulation. There is only sparse evidence regarding ICH related …

Objective Whether intracerebral hemorrhage (ICH) associated with non–vitamin K
antagonist oral anticoagulants (NOAC‐ICH) has a better outcome compared to ICH …

Background Intracerebral hemorrhage (ICH) is associated with high mortality and disability
rates. This study aimed to investigate the relationship between sex, age, study year, risk …

Introduction: Intracerebral haemorrhage (ICH) has an overall incidence of 24.6 per 100,000
person-years and is associated with a high case fatality. Understanding the risk factors for …

Nontraumatic intracerebral haemorrhage (ICH) is a common subtype of stroke with a poor
prognosis, high mortality and long-term morbidity. The incidence of ICH increases with age …

Objective: To compare intracerebral hemorrhage (ICH) volume and clinical outcome of non–
vitamin K oral anticoagulants (NOAC)–associated ICH to warfarin-associated ICH. Methods …

Objective: To compare the neuroimaging profile and clinical outcomes among patients with
intracerebral hemorrhage (ICH) related to use of vitamin K antagonists (VKAs) or direct oral …

Importance Although non–vitamin K antagonist oral anticoagulants (NOACs) are
increasingly used to prevent thromboembolic disease, there are limited data on NOAC …

Objective: In an international collaborative multicenter pooled analysis, we compared
mortality, functional outcome, intracerebral hemorrhage (ICH) volume, and hematoma …